ARCHIVES

ODAC Rejects Amsacrine NDA, Renews Idarubicin

This article is from The Cancer Letter archive.

Vol. 16 No. 35 | September 14, 1990

Download PDF Visit The Full Archive

Related Articles

PA Available

September 12, 1997

NCAB Supports NCI Director’s Call For Increase In Management Funds.

December 8, 2000

Rituximab After CVP Improves Progression-Free Survival

March 27, 2009

NIH funds eight centers for health disparities research.

October 10, 2003

US, Italy Plan Greater Scientific Collaboration

May 16, 2003

Afinitor Suspension Approved For Rare Pediatric Brain Tumor

August 31, 2012